AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 4.270
-0.170 (-3.83%)
Jun 11, 2026, 5:29 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 90.37 million as of June 11, 2026. Its market cap has increased by 29.39% in one year.
Market Cap
90.37M
Enterprise Value
75.80M
Revenue
10.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.27
Market Cap Chart
Since January 9, 2017, AcouSort AB's market cap has increased from 65.36M to 90.37M, an increase of 38.27%. That is a compound annual growth rate of 3.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 90.37M | 50.88% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 123.86M |
| NextCell Pharma AB | 120.08M |
| Simris Group AB (PUBL) | 119.32M |
| Biovica International AB | 105.38M |
| IRLAB Therapeutics AB | 105.32M |
| OncoZenge AB | 96.65M |
| Annexin Pharmaceuticals AB | 91.77M |
| Scandinavian ChemoTech AB | 90.87M |